Cargando…
Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
Metformin had exerted important inhibitory effects in multiple cancers. However, the correlation between metformin and hepatocellular carcinoma (HCC) metastasis, and the relevant mechanisms are still unclear. By quantitative proteomics analysis technique, we found metformin could suppress FGF signal...
Autores principales: | Chengye, Wang, Yu, Tian, Ping, Shao, Deguang, Sun, Keyun, Wang, Yan, Wang, Rixin, Zhang, Rui, Liang, Zhenming, Gao, Mingliang, Ye, Liming, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732803/ https://www.ncbi.nlm.nih.gov/pubmed/29262637 http://dx.doi.org/10.18632/oncotarget.22200 |
Ejemplares similares
-
Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
por: Tian, Yu, et al.
Publicado: (2016) -
Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis
por: Weng, Chang-Mei, et al.
Publicado: (2020) -
Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma
por: Yang, Yanqing, et al.
Publicado: (2017) -
Ghrelin Ameliorates Traumatic Brain Injury by Down-Regulating bFGF and FGF-BP
por: Shao, Xuefei, et al.
Publicado: (2018) -
Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells
Publicado: (1994)